AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Next-generation Sequencing Market (2020 to 2025) - Industry Trends, Share, Size, Growth, Opportunity and Forecast - ResearchAndMarkets.com

December 23, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Dec 23, 2020--

The “Next-generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025” report has been added to ResearchAndMarkets.com’s offering.

ADVERTISEMENT

The global next-generation sequencing (NGS) market is currently witnessing robust growth. Looking forward, the publisher expects the market to register a CAGR of around 17% during 2020-2025.

Next-generation sequencing, or high-throughput sequencing, refers to the process of determining the sequence of nucleotides in a section of the DNA. It includes procedures such as sequencing by synthesis (SBS), ion semiconductor sequencing, nanopore sequencing and single-molecule real-time (SMRT) sequencing. It is a cost-effective solution that offers precise results with high accuracy and speed. This enables the analysis of millions of DNA molecules simultaneously, which facilitates research in the fields of personalized and genetic medicines, agriculture and animal research, and clinical diagnostics.

The increasing prevalence of chronic medical ailments, such as cancer, along with various technological advancements in the field of medical sciences, is one of the key factors driving the growth of the market. Owing to the widespread adoption of liquid biopsies in cancer diagnostics, there has been a significant increase in the utilization of NGS technologies. These technologies utilize cell-free circulating tumor DNA (ctDNA) as a non-invasive cancer biomarker for real-time cancer monitoring and detection. Furthermore, the increasing adoption of genome mapping programs to predict the development of various diseases is also providing a boost to the market growth. Genetic maps are used for guiding scientists to analyze the genes that are responsible for increasing the prevalence of diabetes, heart diseases, asthma, cancer and psychiatric conditions.

Additionally, various technological advancements and integration with the cloud-computing systems for improved data management, are creating a positive impact on the market growth. Other factors, including the declining costs of NGS systems and extensive research and development (R&D) activities in the field of sequencing chemistry, molecular biology and technical engineering, are projected to drive the market further.

ADVERTISEMENT

Companies Mentioned

  • Agilent Technologies
  • Becton Dickinson and Company
  • 10x Genomics
  • BGI Group
  • Eurofins Scientific
  • F. Hoffmann-La Roche AG
  • Illumina Inc.
  • Genewiz
  • Macrogen
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • PerkinElmer
  • Thermo Fisher Scientific
  • Qiagen N.V.
  • GenapSys Inc.

Key Questions Answered in this Report:

  • How has the global next-generation sequencing market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the sequencing type?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global next-generation sequencing market and who are the key players?
  • What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Next-Generation Sequencing Market

5.1 Market Overview

5.2 Market Performance

5.3 Market Forecast

6 Market Breakup by Sequencing Type

6.1 Whole Genome Sequencing

6.1.1 Market Trends

6.1.2 Market Forecast

6.2 Targeted Resequencing

6.2.1 Market Trends

6.2.2 Market Forecast

6.3 Whole Exome Sequencing

6.3.1 Market Trends

6.3.2 Market Forecast

6.4 RNA Sequencing

6.4.1 Market Trends

6.4.2 Market Forecast

6.5 CHIP Sequencing

6.5.1 Market Trends

6.5.2 Market Forecast

6.6 De Novo Sequencing

6.6.1 Market Trends

6.6.2 Market Forecast

6.7 Methyl Sequencing

6.7.1 Market Trends

6.7.2 Market Forecast

6.8 Others

6.8.1 Market Trends

6.8.2 Market Forecast

7 Market Breakup by Product Type

7.1 Instruments

7.1.1 Market Trends

7.1.2 Market Forecast

7.2 Reagents and Consumables

7.2.1 Market Trends

7.2.2 Market Forecast

7.3 Software and Services

7.3.1 Market Trends

7.3.2 Market Forecast

8 Market Breakup by Technology

8.1 Sequencing by Synthesis

8.2 Ion Semiconductor Sequencing

8.3 Single-Molecule Real-Time Sequencing

8.4 Nanopore Sequencing

8.5 Others

9 Market Breakup by Application

9.1 Drug Discovery and Personalized Medicine

9.2 Genetic Screening

9.3 Diagnostics

9.4 Agriculture and Animal Research

9.5 Others

10 Market Breakup by End-User

10.1 Academic Institutes & Research Centers

10.2 Hospitals & Clinics

10.3 Pharmaceutical & Biotechnology Companies

10.4 Others

11 Market Breakup by Region

11.1 North America

11.2 Asia Pacific

11.3 Europe

11.4 Latin America

12 SWOT Analysis

13 Value Chain Analysis

14 Porters Five Forces Analysis

15 Price Indicators

16 Competitive Landscape

16.1 Market Structure

16.2 Key Players

16.3 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/vpu5yv

View source version on businesswire.com:https://www.businesswire.com/news/home/20201223005207/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH GENETICS

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 12/23/2020 07:49 AM/DISC: 12/23/2020 07:49 AM

http://www.businesswire.com/news/home/20201223005207/en